A discussion between Dr. Peter Anglin and Dr. Versha Banerji (Fall 2021)

In this third episode, Dr. Anglin and Dr. Banerji focus on CLL treatment initiation from a patient’s perspective. They share their insights on how to engage a patient in the decision-making process and how to present different options to the patient in an informative and unbiased way. They also discuss how patients’ reactions to the specific aspect of treatments guide their consultation and lead to the ultimate treatment-related decision.

Peter Anglin, MD, FRCPC, MBA Hematologist/Oncologist Physician Lead, Stronach Regional Cancer Centre Newmarket, ON

Versha Banerji MD, FRCPC Clinician Scientist and Associate Professor, Faculty of Medicine, Departments of Internal Medicine, Biochemistry & Medical Genetics, Max Rady School of Medicine, Rady Faculty of Health Sciences, University of Manitoba CLL clinic and research Co-Lead Hematologist, CancerCare Manitoba Senior Scientist, CancerCare Manitoba Research Institute Adjunct Professor, Department of Biology, University of Winnipeg

This podcast is intended for Healthcare Professionals only. Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities. This program was made possible through Master Clinician Alliance, which graciously acknowledges the educational grant and in-kind support provided by AbbVie Corporation.